Those of you who’ve been aboard the good ship Gumshoe for a while know that I’m not exactly a marijuana stock enthusiast… but still, when folks keep asking me to ID the pot stocks being teased by various newsletters, I do aim to please. So this time we’re looking at Matt McCall’s pitch, which looks […]
A version of this article was originally published on November 8, 2018, but we have gotten a huge number of questions and the Motley Fool is again aggressively promoting this same basic pitch, so we’re re-posting and updating this solution for you (along with a bonus at the end). The latest variation of the ad […]
Gold had its worst day yesterday since 2016, so that was a little shock to the system — mostly, I think, because the latest leaks and Tweets about the China trade dispute were relatively optimistic, with meetings scheduled for next month. It’s hard to imagine we’re going to have a “real” trade deal before the […]
This one hit the radar on Friday amongst the carnage in pot stocks. It was one of the few pot stocks up Friday as the sector was getting hit again. I’d recommend going to their investor relations page and listening to both their latest earnings call and August Investor presentation. These are ex-mortgage bankers that […]
Things began slowly this week after a weekend of decadence in Las Vegas… what impressions did I have of Sin City? People aren’t gambling as much as the last time I was here a few years ago, the tables and slot machines were not so crowded, but there were still some big crowds of people […]
We’ve seen plenty of “get in before the IPO” pitches over the years, and that has only accelerated as more and more companies have taken advantage of the JOBS Act to raise money under easier rules — particularly the “democratization” of private funding to allow unaccredited investors to invest in small private companies. Combining that […]
What’s going on with the market this week? Well, the accepted narrative keeps shifting — first we had trade war panic as Trump announced new tariffs last week, then celebration as those tariffs were delayed to ‘save Christmas’, and the market is overly obsessed with the high-level game of chicken being played by Trump and […]
This article was originally published on March 15, 2019, when we first saw the ad — there is a new version now, slightly updated but teasing the same stock and promising a new “hot” deadline, so we’re republishing this here with very minor updates. This particular ad is of the “Indiana Jones” variety, which is […]
I did miss a few things while I was on vacation, and one of them was the briefly-teased “First official marijuana recommendation” from Motley Fool co-founder Tom Gardner… and that intrigued me enough to go back and dig into the ad from early July, even though the ad is no longer active and the service […]
Eddy Elfenbein is out with a teaser pitch for his Growth Stock Advisor newsletter, and, like so many other pot-focused touts we’ve seen in years past, it’s essentially all about the fact that you need to get in today on a once-in-a-generation opportunity in the crazy-fast-growth of the legal marijuana industry. I don’t think I’ve […]
This article was originally published on March 26, the ad in question continues to circulate unchanged but we have lightly updated our coverage below to reflect some changes in the company… including the 40% drop in the share price since the ad started running. Matthew Carr at the Oxford Club is pitching a new marijuana […]
There’s no more cyclical stock than a semiconductor stock, and we’re seeing the whipsaw slash through that market now as trade sentiment weakens and pundits begin to see some weakness in the economy, particularly in the employment numbers, and the Federal Reserve fuels that uncertainty by essentially promising a rate cut in their attempt to […]
oxford club. it is a canadian co I think– says not on USexchanges. thoughts it is $3
Today we have the uncertain pleasure of checking out a teaser pitch from James Altucher, who one of our readers referred to as the “white Don King of the stock gurus” — he’s peddling subscriptions to Altucher’s Investment Network (that’s his “entry level” letter, $79/year), and the bait he dangles out is his “special report” […]
The other four stocks teased by Jimmy Mengel for his Crow’s Nest newsletter aren’t necessarily as interesting (story wise) as the one we looked at yesterday… but I promised to try to ID them for you, so let’s jump right in. I should let you know, first, that some of these are guesses. As usual, […]
Everyone loves marijuana stocks, perhaps even more than everyone loved bitcoin stocks a year and a half ago, and that fascination has been longer-lasting than I would have guessed… fed not only by the reminder of those spikes in penny pot stocks in the first few years of state legalization, then these first couple quarters […]
Did anyone watch Matt McCall’s teaser April 4th – Marijuana IPO; I did not. ”This pot stock could soar … starting today (April 4th) A little-known, but HUGE event is set to take place in the pot industry TODAY (April 4th). Get in early, and you could turn a tiny grubstake of $250 into a […]
The folks at Crowdability are pitching their Micro-Cap Advantage newsletter ($1,495/year “on sale,” renews at $1,995) by using one of those oh-so-special video ad presentations that’s touted as a “live event” … … and as luck would have it, I didn’t feel like sitting through a live sales pitch last week, so I waited to […]
Marijuana-focused higher-price newsletter, stated aim is “to weed through the emerging marijuana industry to find the best, most potentially lucrative penny pot plays on the market.”
We first published this teaser solution on January 8, and I’m continuing to get the ad forwarded to me here at Gumshoe HQ pretty much every day… so I thought I’d repost this solution and provide you with a bit of an update (the story has changed a little, and I’ve learned a little more […]
This teaser pitch has been around for a few weeks, but I haven’t gotten around to covering it until now… call it marijuana fatigue, just plain laziness, or a surfeit of other hypetastic pitches, but it just didn’t rise to the top. Questions have rolled in from readers pretty consistently, though, so I’m finally digging […]
Paul Mampilly’s huge marketing machine at Banyan Hill tends to drive a lot of questions our way, and this latest one about a medical marijuana stock caught my eye… but I should warn you up front that it’s a teaser ad that’s very light on clues… today we’re going to have to do some guessing. […]
This Tiny Little Pot Company Already Has the Most Profitable Retail Store in America… WHAT IS IT? Starting Soon, Its Stock Could Be the Most Profitable Investment on the Market You’ve likely never heard of this new marijuana company… But their stores are already pulling in MORE cash per square foot than those ”fruit” stores […]
By MONEY MORNING STAFF REPORTS, Money Morning • January 9, 2019 2019 is gearing up to see a record number of high-flying cannabis IPOs hit the market – each capable of unleashing millions of dollars into the market. It’s a true investing phenomenon. Within the next five weeks, we could see as many as 10 […]
ISRACANN Biosciences (3 marijuana licences acquired in Israel) merging or being acquired by Atlas Blockchain (formerly Atlas Cloud). ISRACANN (AKE ON CSE). Offer coming out $0.51 per share and includes $0.34 warrant to be exercised within 2 years. While concept is focused on producing pot at $0.40 per gram, stock is halted as they properly […]
This article originally ran on October 25, the ad is again circulating in slightly different form and sending a lot of questions our way, so we’re re-publishing it here for you today… the basic spiel and the stock are still the same, though they’re being used to pitch a different newsletter. The stock has bumped […]
Does anyone know if there is any truth in the recent story about APHA management making fake investments with company money?
I’m not going to keep you in suspense. The two proposed miracle cures are L-carnitine (an amino acid) and “Delta 8,” which in a previous Doc Gumshoe disquisition was unmasked as Delta 8 tetrahydrocannabinol, or Delta 8 THC (Δ8 THC), which is one of perhaps a hundred cannabinoids found in the cannabis plant, as […]
The Money Map folks have decided that it’s time to go “all in” on cannabis, and for them that means starting a new investment research business that they call the National Institute for Cannabis Investors, and selling memberships in that group by teasing their favorite “special reports” on some appealing marijuana stocks that they’ll give […]
Entry level research service that promises a new “Cannabis Investment Package” each month, recommending different stocks in the sector.
Hi Travis and all, I’ve just joined as a premium member after reading for months and months without being on discussions. So now that I can post- does anyone have information on mania 2.0? Thank you!! Kerri in Michigan
The next wireless standard to be adopted by telecom service providers might be the biggest one since 3G enabled the first real “high speed” data and reasonably useful internet access by smart phones. And new wireless standards are always of interest to investors, not least because the growth of smartphones has tracked the improving networks […]
Marijuana speculation is all the rage these days, with most punters focused on the first legal sales of recreational marijuana that will be taking place in Canada tomorrow and the crazy stock market gyrations of the larger Canadian growers like Canopy Growth and Aurora and Tilray and their ilk… … and what makes some of […]
I guess now pretty much everyone has jumped aboard the Marijuana bandwagon — the Motley Fool is a bit later to the party, having just announced its Marijuana Masters investing service ($1,499, no refunds), helmed by David Kretzmann (a new name to me), so let’s see what it is that the typically much more mainstream […]
New trading service started by the Fool in October 2018, higher-cost/no-refund service with a portfolio of cannabis-related picks.
This past week or so has been a “holy crap” one for those who are overexposed to momentum stocks — you know the ones, they’re the stocks I keep buying in small chunks but that are very expensive and a little frightening, the ones in my portfolio that I put in that category would be […]
Have you been watching what’s going on with the trendy pot stocks lately? Holy crap. This reminds me now of 1999 more than it reminds me of the cryptocurrency bubble of this past winter — these larger marijuana companies, like many of the dot com companies (and unlike most cryptos, of course), are real businesses […]
Michael Robinson runs the technology/venture newsletters for Money Map Press, and he’s out with yet another marijuana promo — after all, any newsletter that doesn’t jump on board the marijuana stock rocket is deemed pretty much irrelevant these days, just like any newsletter without a “crypto expert” was ignored in January. So yes, now Michael […]
A few purchases to talk to you about today, and a couple other notes as we go… mostly on the theme of risk and safety, as we close out a week with lots of news-driven volatility. Ready? Innovative Industrial Properties (IIPR) is, in some ways, a fun way to “play” the marijuana boom with less […]
Before you get sucked into reading more of my blather, take a moment and read the Wall Street Journal if you’ve got a copy nearby or an online subscription — not the whole thing, but read Christopher Mims’ column The World Isn’t as Bad as Your Wired Brain Tells You. It’s an unusually brief and […]
Today’s article is a lightly updated revision of one that appeared on November 3, 2016, when an earlier “pre-election” version of the same ad was running. The hints about individual stocks are the same in the ad today, as is much of the rest of the language, though back then it was an urgent “pre-election” […]
Hello, dearest Irregular friends! I’ve been spending part of my day working on our new “Ask A Stupid Question” project, but don’t worry, I wouldn’t forget about my favorite Friday File readers! So what’s up this week? There are a few minor updates in the Real Money Portfolio that I’ll get to at the end, […]
This one’s not exactly a tightly-controlled secret (though the ad makes it sound like one), but we’ll put the Thinkolator on the case anyway… we’ve gotten lots of questions about the latest marijuana pitch from Jimmy Mengel, who is advertising subscriptions to his Marijuana Manifesto service ($1,999/year) — seems that plenty of people want to […]
The ides of February are dismal and dreary here in the wet and grey Pioneer Valley of Massachusetts, but we remain hopeful of the sunshine to come. What do I have to share with you, dear Irregulars, as we seek a little brightness to end the week? Well, I do have a few buys to […]
And our Annual Review proceeds apace… on a day when the market is showing signs of actually having a meaningful correction, thanks to Friday jitters and inflation worries and rising interest rates… so cross your fingers for better prices in the week to come (I did buy a couple positions this week, but as I […]
Free letter that covers “all topics within the cannabis business and investment landscape”.
Many Gumshoe readers wanted me to follow up on yesterday’s marijuana article right away, identifying the other two stocks hinted at in the ads for Nick Giambruno’s Crisis Investing… and we aim to please, so let’s jump right into it. If you missed part one, you can check that out here — the overriding argument […]
This is the headline that so many readers have been asking about in recent weeks… “URGENT: If you missed America’s ‘pot stock mania,’ here’s your second chance to become a marijuana millionaire. This 58¢ pot stock is set to soar on October 31, 2017, when Canada votes to legalize marijuana for the entire country.” That’s […]
Jimmy Mengel is pushing a new Marijuana stock, one which apparently just recently became public, for his Marijuana Manifesto service… so what is it? He calls it a “Marijuana Streaming” company, so that’s music to my ears — I’ve long had a fondness for the “free upside, limited downside” of the streaming and royalty companies […]
Jimmy Mengel has pitched pot stocks several times before, but now he’s upped the ante and is launching a marijuana-only newsletter service called The Marijuana Manifesto… which is probably as good a sign of a market top as we could hope for, but we’ll see. In launching this service, which he’s selling for about $2,000 […]
Marijuana-focused stock advisory launched by Jimmy Mengel at Angel Publishing in early 2017, he has been recommending marijuana stocks for his much less expensive Crow’s Nest advisory since 2015 or so.
Individual investors are obsessed with marijuana stocks these days, hoping to get in on pot stocks the same way Joe Kennedy got in on whiskey in the days before prohibition was lifted… so it certainly caught our readers eyes when Hilary Kramer started promoting that she has “The One Stock That Could Make You a […]
This week I’ve got a little teaser decipherization for you to get us started, and we’ve also got a new piece from Dr. KSS… and I’ve got some updated thoughts on a few other stocks at the end of today’s piece. The teaser? Well, it’s been circulating for a few weeks now, and it caught […]
This article was originally published on December 17, it has not been edited or revised. The ad from Jimmy Mengel’s The Crow’s Nest is apparently circulating heavily again, because questions are percolating through to me about these “secret marijuana stocks” again… so we’re moving it to the top of the list today for your edutainment. […]
This tread is created for serious cannabis investors to share K.A.S.H. by providing ideas, diligence, links, equities, etc. with like-minded individuals.
“The Greatest Medical Breakthrough in 72 Years… “One Drug to End All Pain — Naturally “A new revolutionary drug called ‘Delta-9’ will send a small group of companies skyrocketing for life-altering gains… starting December 31, 2014. “The last time something like this happened 72 years ago… investors had the opportunity to turn every $1,000 into […]
Well, again Frank Curzio’s Phase 1 Investor wins the prize for “teaser ad most Gumshoe readers are asking about” … so let’s give it a gander for you. Phase 1 is a premium-priced ($3,500 is the current “on sale” cost) small cap newsletter published by Stansberry, and it tends to be among the most-requested letters […]
Who has the most experience the large Medical Companies or new upstarts. Of course Capital investment does not look like a problem.
OK. So I own a few shares of this penny stock. Up a few bucks. Would love some rational analysis of this stock. Pump and dump or a real long term winner. Based on current legislative trends in a few states and liberal federal government leanings, Marijuana looks pretty good. I like it. Please drag […]
Long time reader, few months ago subscriber, one of a very few newsletters I read, and def my most favorite. So platitudes aside, I would really love to know what we all think about existing/upcoming marijuana stocks. With mdeical pot on the rise and now with Washington/Colorado legalizing recreational use, it would seem that the […]
I was wondering what your take on the legalization on marijuana stands for investors? Any picks or suggestions on what to look for on this?